TITLE

Pharma Clinical & FDA Action Update: April 2013

PUB. DATE
May 2013
SOURCE
BioWorld Insight;5/13/2013, Vol. 21 Issue 20, p22
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
A table is presented on the pharma clinical and the U.S. Food and Drug Administration action update as of April, 2013 which lists pharmaceutical products of several pharmaceutical companies including Cipla Ltd. in Mumbai, India, Pfizer Inc. in New York, and UCB SA, in Brussels, Belgium.
ACCESSION #
87619297

 

Related Articles

  • FDA Actions.  // CenterWatch Monthly;Feb2014, Vol. 21 Issue 2, p18 

    A chart on regulatory actions taken by the U.S. Food & Drug Administration (FDA) recently including company names, drug name and FDA incation is presented.

  • FDA Submissions, Approvals & Other Actions: March 2011.  // BioWorld Insight;4/18/2011, Vol. 19 Issue 16, p23 

    A chart is presented depicting the submission, approval and other actions by U.S. Food and Drug Administration to various pharmaceutical companies worldwide including Genus Oncology LLC, Insys Therapeutics Inc., and Seattle Genetics Inc.

  • FDA Approvals In December.  // BioWorld Insight;1/23/2012, Vol. 20 Issue 4, p6 

    A table is presented which lists the companies, along with their drugs being approved by the U.S. Food and Drug Administration (FDA) in December 2011, including Antares Pharma Inc.'s Oxybutynin gel, Merck & Co. Inc.'s Isentress, and ViroPharma Inc.'s Vancocin.

  • FDA Submissions, Approvals & Other Actions: December 2011.  // BioWorld Insight;1/23/2012, Vol. 20 Issue 4, p28 

    A table is presented which lists the pharmaceutical companies, along with their products that are submitted and approved by the U.S. Food and Drug Administration (FDA) as of December 2011, including Pfizer Inc.'s Tofacitinib, Merck & Co. Inc.'s Isentress, and Affymax Inc.'s Peginesatide.

  • FDA Submissions, Approvals & Other Actions: February 2013.  // BioWorld Insight;3/11/2013, Vol. 21 Issue 11, p22 

    A table is presented which provides information on the submissions, approvals, and other actions made by the U.S. Food and Drug Administration (FDA) for several drugs from various pharmaceutical companies as of February 2013, which include Algeta ASA, Apogenix GmbH, and Celgene Corp.

  • FDA Approvals In April.  // BioWorld Insight;5/16/2011, Vol. 19 Issue 20, p7 

    A table is presented that lists the U.S. Food and Drug Administration (FDA) approvals to several pharmaceutical companies in April 2011 including AstraZeneca PLC, Centocor Ortho Biotech Inc., and Merck & Co. Inc.

  • FDA warns Pfizer to report Rx problems promptly.  // Drug Topics;5/20/96, Vol. 140 Issue 10, p8 

    Reports on the US Food and Drug Administration's (FDA) warning letter to Pfizer regarding the company's tardiness in reporting unexpected side effects with its prescription drugs.

  • Pfizer fined. Harrington, John // Crain's New York Business;12/6/93, Vol. 9 Issue 49, p42 

    Reports on the $290,000 fine imposed by the Food and Drug Administration (FDA) on the Manhattan, New York City-based drug manufacturer Pfizer Inc. for marketing a pump that was modified without the FDA approval. Imposition of the fine through the Infusaid Inc. of Pfizer Incorporated.

  • FDA approves Pfizer Viagra drug.  // Chemical Market Reporter;04/06/98, Vol. 253 Issue 14, p19 

    Announces that the Food and Drug Administration has approved the market introduction of the drug Viagra developed by Pfizer Inc. for the treatment of erectile dysfunction effective April 1998. Revenue expectations from sale of drug.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics